Aster DM Healthcare Limited
ASTERDM · Hospitals · NSE
₹680
Current Market Price
Fair Value (DCF)
₹173
Margin of Safety
-74.5%
Updated just now
YieldIQ Score
48/100
Piotroski F-Score
6/9
Economic Moat
Narrow
Confidence
33%
ROE
147.3%
Debt/Equity
0.00
WACC
12.8%
Market Cap
₹0.35 Lakh Cr
Quality & Valuation
Neutral model outputs — no recommendations.
ROCE
10.1%
Return on capital employed
EV / EBITDA
46.7×
Enterprise multiple
Debt / EBITDA
2.5×
Leverage vs earnings
Interest Coverage
5.4×
EBIT covers interest
Current Ratio
2.16×
Short-term liquidity
Asset Turnover
0.64×
Revenue per ₹ of assets
Revenue CAGR (3Y)
-29.1%
3-year revenue growth
Revenue CAGR (5Y)
-13.2%
5-year revenue growth
DCF Scenario Analysis
vs CMP ₹679.9
Bear case
₹104
MoS -553.8%
Base case
₹173.22
MoS -292.5%
Bull case
₹229.01
MoS -196.9%
Ratio Trends
ASTERDM · last 8 annual periods
ROE
147.3%
ROCE
14.7%
Operating Margin
—
Debt / Equity
0.55×
PE
26.2×
EV / EBITDA
12.3×
Historical Financials
ASTERDM · Annual, last 5 years· amounts in ₹Cr unless noted
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | CAGR |
|---|---|---|---|---|---|---|
| Revenue | ₹8608 Cr | ₹10.3K Cr | ₹11.9K Cr | ₹3699 Cr | ₹4069 Cr | -17.1% |
| EBITDA | — | ₹1534 Cr | ₹1061 Cr | ₹1355 Cr | ₹833 Cr | -14.2% |
| EBIT | ₹495 Cr | ₹893 Cr | ₹863 Cr | ₹383 Cr | — | -6.2% |
| PAT | ₹178 Cr | ₹601 Cr | ₹475 Cr | ₹212 Cr | ₹5378 Cr | +134.5% |
| EPS (diluted) | ₹2.97 | ₹10.57 | ₹8.54 | ₹3.60 | — | +4.9% |
| CFO | ₹1569 Cr | ₹1313 Cr | ₹1834 Cr | ₹158 Cr | ₹425 Cr | -27.9% |
| CapEx | — | — | — | — | ₹-357 Cr | — |
| FCF | — | — | — | — | ₹68.3 Cr | +0.0% |
| Total Assets | — | ₹12.5K Cr | ₹14.9K Cr | ₹18.0K Cr | ₹6606 Cr | -14.8% |
| Total Debt | — | — | ₹975 Cr | ₹223 Cr | ₹2018 Cr | +19.9% |
| Shareholders' Equity | — | — | ₹4448 Cr | ₹4560 Cr | ₹3651 Cr | -4.8% |
CAGR computed across the visible window. Signs reverse if start value is zero or negative.
Peer Comparison
ASTERDM vs 5 closest peers by market-cap band
| Peer | MoS | Score | Verdict | ROE | PE |
|---|---|---|---|---|---|
| NH NH | — | — | Pending | 21.8% | — |
| MEDANTA MEDANTA | — | — | Pending | 14.2% | — |
| KIMS KIMS | — | — | Pending | 15.9% | — |
| FORTIS FORTIS | — | — | Pending | 8.4% | — |
| MAXHEALTH MAXHEALTH | — | — | Pending | 11.5% | — |
Click a ticker to view its fair-value analysis.
Dividend History
5 ex-dividend events on file. Source: NSE corporate-actions feed.
Total paid (5Y)
₹128.00/sh
Last payout
2026-04-02
₹3.00
Peak payout
₹118.00
Trailing yield
0.59%
Amounts parsed from NSE subject lines; percent-of-face-value declarations are not converted and shown as missing.
Reverse DCF
Market-implied growth
What FCF growth is priced in →
Risk Analysis
Volatility & drawdown
Risk profile of ASTERDM →
DuPont
ROE decomposition
Why ROE is what it is →
Technicals
RSI, MACD, MAs
Reference indicators →
News & Filings
Recent activity
BSE filings + news for ASTERDM →
Compare
Head-to-head with peers
Compare ASTERDM side by side →
Run Full Interactive Analysis
Interactive DCF sliders, sensitivity heatmap, peer comparison, and more.
Analyse ASTERDMNow →Model estimates using publicly available data. Not investment advice. YieldIQ is not registered with SEBI as an investment adviser or research analyst. Past performance does not guarantee future results.